An Exploration of Candidates for Neoadjuvant Treatment in Resectable Pancreatic Cancer
NCT06129812 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1132
Last updated 2023-11-13
Summary
An Exploration of Candidates for Neoadjuvant Treatment in Resectable Pancreatic Cancer
Conditions
- Pancreatic Cancer
- Neoadjuvant
Interventions
- DRUG
-
Neoadjuvant treatment
Intravenous gemcitabine-based combination regimens or FOLFIRINOX were included in NAC.
Sponsors & Collaborators
-
Seoul National University Hospital
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-01-31
- Primary Completion
- 2021-12-31
- Completion
- 2021-12-31
More Related Trials
-
Adjuvant Gemcitabine and Cisplatin Followed by Chemoradiation for Resected Pancreatic Cancer
NCT01396681 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 2 Trial of Neoadjuvant Modified FOLFIRINOX Chemotherapy for Resectable Pancreatic Adenocarcinoma
NCT05066802 ·Status: UNKNOWN ·Phase: PHASE2
-
Investigation of the Optimal Duration of Neoadjuvant Therapy for Resectable Pancreatic Cancer
NCT06809374 ·Status: COMPLETED
-
Surgical Results of Resection of Locally Advanced Pancreatic Cancer
NCT06206382 ·Status: NOT_YET_RECRUITING
-
Survival Analysis After Neoadjuvant Therapy in Patients With Resectable Pancreatic Cancer and Risk Factors
NCT05181605 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Neoadjuvant Chemotherapy for Pancreatic Cancer Followed by GS and GnP
NCT05268692 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Neoadjuvant FDR GX in Locally Advanced Pancreatic Cancer
NCT01268384 ·Status: COMPLETED ·Phase: PHASE2
-
Neoadjuvant Chemoradiation in Patients With Borderline Resectable Pancreatic Cancer
NCT01458717 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Preoperative Chemoradiotherapy With Gemcitabine for Resectable Pancreatic Carcinoma
NCT01333124 ·Status: TERMINATED ·Phase: PHASE2
-
Does Recurrent Pancreatic Cancer Really Have Similar Outcome Compared With Primary Metastatic Pancreatic Cancer?
NCT06921252 ·Status: COMPLETED
-
Neoadjuvant Chemotherapy and Stereotactic Radiosurgery to Pancreatectomy for Patients With Borderline Resectable Pancreatic Cancer
NCT03199144 ·Status: WITHDRAWN ·Phase: PHASE2
-
Neoadjuvant Treatment in Resectable Pancreatic Cancer
NCT01900327 ·Status: TERMINATED ·Phase: PHASE3
-
Survival Rate and Treatment Cost in Patients With Pancreatic Cancer: An Analysis Using NHIS Database and K-PaC Registry Focusing on Liposomal Irinotecan
NCT04984174 ·Status: COMPLETED
-
Pembrolizumab Plus Chemotherapy in 1st Line Treatment of Pancreatic Cancer
NCT04447092 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Single-cell Sequencing Analysis of Resectable/Borderline Resectable Pancreatic Cancer Patients
NCT06310902 ·Status: RECRUITING
-
Survival, Quality of Life and Resectability in Locally Advanced Pancreatic Cancer
NCT05356039 ·Status: RECRUITING
-
Phase I Study of Neoadjuvant Chemotherapy for Patients With Borderline Resectable Pancreatic Cancer.
NCT02506803 ·Status: UNKNOWN ·Phase: PHASE1
-
Neoadjuvant S-1 and Concurrent Radiotherapy for Borderline Resectable Pancreatic Cancer
NCT02459652 ·Status: COMPLETED ·Phase: PHASE2
-
A Longitudinal, Observational Biomarker Study in Pancreatic Cancer Patients Receiving Chemotherapy
NCT04281511 ·Status: COMPLETED
-
Irinotecan Liposome for Resectable Pancreatic Cancer With or Without Addebelizumab
NCT06172036 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Second-Line Adjuvant Therapy With Nab-Paclitaxel Plus Gemcitabine Versus Oxaliplatin Plus Folinic Acid and Fluorouracil for Gemcitabine-Refractory Pancreatic Cancer After Curative Resection
NCT02506842 ·Status: UNKNOWN ·Phase: PHASE3
-
Neoadjuvant Modified FOLFIRINOX in Borderline Resectable Pancreatic Cancer
NCT02749136 ·Status: COMPLETED ·Phase: PHASE2
-
Nivolumab in Combination With Chemotherapy Pre-Surgery in Treating Patients With Borderline Resectable Pancreatic Cancer
NCT03970252 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Platform Study of Neoadjuvant and Adjuvant Immunotherapy for Patients With Resectable Adenocarcinoma of the Pancreas
NCT02451982 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Neoadjuvant Nab-Paclitaxel and S-1 in Borderline Resectable Pancreatic Cancer
NCT03850769 ·Status: UNKNOWN ·Phase: PHASE2